摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Carbamic acid, (4-methylphenyl)-, 1-phenylethyl ester | 90591-46-1

中文名称
——
中文别名
——
英文名称
Carbamic acid, (4-methylphenyl)-, 1-phenylethyl ester
英文别名
1-phenylethyl N-(4-methylphenyl)carbamate
Carbamic acid, (4-methylphenyl)-, 1-phenylethyl ester化学式
CAS
90591-46-1
化学式
C16H17NO2
mdl
——
分子量
255.316
InChiKey
AZDXEDUCCRCLAL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    345.7±31.0 °C(Predicted)
  • 密度:
    1.144±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    Carbamic acid, (4-methylphenyl)-, 1-phenylethyl ester碘甲烷 在 sodium hydride 作用下, 以 四氢呋喃 、 mineral oil 为溶剂, 反应 24.5h, 生成 methyl p-tolyl carbamic acid 1-phenylethyl ester
    参考文献:
    名称:
    N to C Aryl Migration in Lithiated Carbamates: α-Arylation of Benzylic Alcohols
    摘要:
    We report a new mode of reactivity displayed by lithiated O-benzyl carbamates carrying an N-aryl substituent: upon lithiation, the N-aryl group is transferred cleanly from N to C. An arylation of the carbamate results, providing a route to alpha,alpha-arylated secondary or tertiary alcohols. We also report density functional theory calculations supporting the proposal that arylation proceeds through a dearomatizing attack on the aromatic ring, a significantly lower energy pathway than the 1,2-acyl transfer observed with related N-alkyl carbamates.
    DOI:
    10.1021/ja808959e
  • 作为产物:
    描述:
    参考文献:
    名称:
    N to C Aryl Migration in Lithiated Carbamates: α-Arylation of Benzylic Alcohols
    摘要:
    We report a new mode of reactivity displayed by lithiated O-benzyl carbamates carrying an N-aryl substituent: upon lithiation, the N-aryl group is transferred cleanly from N to C. An arylation of the carbamate results, providing a route to alpha,alpha-arylated secondary or tertiary alcohols. We also report density functional theory calculations supporting the proposal that arylation proceeds through a dearomatizing attack on the aromatic ring, a significantly lower energy pathway than the 1,2-acyl transfer observed with related N-alkyl carbamates.
    DOI:
    10.1021/ja808959e
点击查看最新优质反应信息

文献信息

  • METHODS FOR TREATING HEPATITIS C
    申请人:Karp Gary M.
    公开号:US20100292187A1
    公开(公告)日:2010-11-18
    The present invention provides compounds, pharmaceutical compositions, and methods of using such compounds or compositions for treating infection by a virus, or for affecting viral IRES activity.
    本发明提供了化合物、药物组合物以及使用这些化合物或组合物治疗病毒感染或影响病毒IRES活性的方法。
  • META-BENZAMIDINE DERIVATIVES AS SERINE PROTEASE INHIBITORS
    申请人:Protherics Molecular Design Limited
    公开号:EP1009758A1
    公开(公告)日:2000-06-21
  • US7973069B2
    申请人:——
    公开号:US7973069B2
    公开(公告)日:2011-07-05
  • [EN] META-BENZAMIDINE DERIVATIVES AS SERIN PROTEASE INHIBITORS<br/>[FR] DERIVES DE META-BENZAMIDINE COMME INHIBITEURS DE SERINE PROTEASE
    申请人:——
    公开号:WO1999011658A1
    公开(公告)日:1999-03-11
    [EN] The invention relates to serine protease inhibitor compound of formula (I), where R1 and R2 each independently is hydrogen or hydroxyl, alkoxyl, alkyl, aminoalkyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, acyloxymethoxycarbonyl or alkylamino optionally substituted by hydroxy, alkylamino, alkoxy, oxo, aryl or cycloalkyl; each R3 independently is R1, R2, amino, halo, cyano, nitro, thiol, alkylthio, alkylsulfonyl, alkylsulphenyl, alkylsulphonamido, alkylaminosulphonyl, haloalkoxy and haloalkyl; each X independently is C, N, O or S atom or a CO, CR1, C(R1)2 or NR1 group, at least one X being C, CO, CR1 or C(R1)2, with the proviso that if the benzamidine group is unsubstituted and the X-X group is -CH2C(R1)2-, then R1 is hydrogen or is attached to the alkylene carbon atom by a heteroatom; L is an organic linker group containing 1 to 5 backbone atoms selected from C, N, O and S, or a branched alkyl or cyclic group; Y is a nitrogen atom or a CR1 group or Y and L taken together form a cyclic group; Cy is a saturated or unsaturated, mono or polycyclic, homo or heterocyclic group optionally subsituted by groups R3 or phenyl optionally substituted by R3; Lp is a lipophilic organic group, selected from an alkyl, heterocyclic, alkenyl, alkaryl, cycloalkyl, polycycloalkyl, cycloalkenyl, aryl, aralkyl or haloalkyl group or a combination of two or more such groups optionally substituted by one or more of oxa, oxo, aza, thio, halo, amino, hydroxy or R3 groups; D is a hydrogen bond donor group; and n is 0, 1 or 2 and salts thereof.
    [FR] L'invention concerne des composés d'inhibiteurs de sérine protéase de la formule I (dans laquelle R1 et R2 sont chacun indépendamment hydrogène ou hydroxyle, alcoxy, alkyle, aminoalkyle, hydroxyalkyle, alcoxyalkyle, alcoxycarbonyle, acyloxyméthoxycarbonyle ou alkylamino éventuellement substitué par hydroxy, alkylamino, alcoxy, oxo, aryle ou cycloalkyle; chaque R3 est indépendamment R1, R2, amino, halo, cyano, nitro, thiol, alkylthio, alkylsulfonyle, alkylsulfényle, alkylsulfonamido, alkylaminosulfonyle, haloalcoxy et haloalkyle; chaque X est indépendamment un atome de C, N, O ou S ou un groupe CO, CR1, C(R1)2 ou NR1, au moins un X étant C, CO, CR1 ou C(R1)2, à condition que si le groupe benzamidine est non substitué et le groupe X-X est -CH2C(R1)2-, alors R1 est hydrogène ou est fixé à l'atome de carbone d'alkylène par un hétéroatome; L est un groupe de liaison organique contenant 1 à 5 atomes de squelette sélectionnés dans le groupe formé par C, N, O et S ou un alkyle ou groupe cyclique ramifié; Y est un atome de nitrogène ou un groupe CR1 ou Y et L pris ensemble forment un groupe cyclique; Cy est un groupe saturé ou insaturé, mono ou polycyclique, homo ou hétérocyclique éventuellement substitué par des groupes R3 ou un phényle éventuellement substitué par R3; Lp est un groupe organique lipophile, sélectionné dans le groupe formé par un groupe alkyle, hétérocyclique, alcényle, alkaryle, cycloalkyle, polycycloalkyle, cycloalcényle, aryle, aralkyle ou haloalkyle ou une combinaison de deux ou plusieurs de ces groupes éventuellement substitués par un ou plusieurs groupes oxa, oxo, aza, thio, halo, amino, hydroxy ou R3; D est un groupe donneur de liaison hydrogène; et n désigne 0, 1 ou 2. L'invention concerne également des sels de ces composés.
  • N to C Aryl Migration in Lithiated Carbamates: α-Arylation of Benzylic Alcohols
    作者:Jonathan Clayden、William Farnaby、Damian M. Grainger、Ulrich Hennecke、Michele Mancinelli、Daniel J. Tetlow、Ian H. Hillier、Mark A. Vincent
    DOI:10.1021/ja808959e
    日期:2009.3.18
    We report a new mode of reactivity displayed by lithiated O-benzyl carbamates carrying an N-aryl substituent: upon lithiation, the N-aryl group is transferred cleanly from N to C. An arylation of the carbamate results, providing a route to alpha,alpha-arylated secondary or tertiary alcohols. We also report density functional theory calculations supporting the proposal that arylation proceeds through a dearomatizing attack on the aromatic ring, a significantly lower energy pathway than the 1,2-acyl transfer observed with related N-alkyl carbamates.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐